270 related articles for article (PubMed ID: 25727598)
1. Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma.
Astudillo PP; Durairaj P; Chan HS; Héon E; Gallie BL
J AAPOS; 2015 Feb; 19(1):86-7. PubMed ID: 25727598
[TBL] [Abstract][Full Text] [Related]
2. No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma.
Yousef YA; Halliday W; Chan HS; Héon E; Gallie BL; Dimaras H
Can J Ophthalmol; 2013 Dec; 48(6):524-8. PubMed ID: 24314416
[TBL] [Abstract][Full Text] [Related]
3. Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
Kotlyar B; Shapiro M; Blair M
Ophthalmic Surg Lasers Imaging Retina; 2019 Apr; 50(4):248-252. PubMed ID: 30998248
[TBL] [Abstract][Full Text] [Related]
4. Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC; Dimaras H; Chan HS; Héon E; Gallie BL
Arch Ophthalmol; 2011 Jun; 129(6):738-45. PubMed ID: 21670340
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
6. Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma.
Francis JH; Marr BP; Schaiquevich P; Kellick MG; Abramson DH
Br J Ophthalmol; 2015 Oct; 99(10):1320-2. PubMed ID: 25926516
[TBL] [Abstract][Full Text] [Related]
7. Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma.
Tse BC; Kaste SC; Brennan R; Orr B; Wilson MW
Ophthalmology; 2015 Feb; 122(2):435-7. PubMed ID: 25439599
[No Abstract] [Full Text] [Related]
8. A phase I study of periocular topotecan in children with intraocular retinoblastoma.
Chantada GL; Fandino AC; Carcaboso AM; Lagomarsino E; de Davila MT; Guitter MR; Rose AB; Manzitti J; Bramuglia GF; Abramson DH
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1492-6. PubMed ID: 18978345
[TBL] [Abstract][Full Text] [Related]
9. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Delrish E; Jabbarvand M; Ghassemi F; Amoli FA; Atyabi F; Lashay A; Soleimani M; Aghajanpour L; Dinarvand R
Exp Eye Res; 2021 Mar; 204():108423. PubMed ID: 33453276
[TBL] [Abstract][Full Text] [Related]
11. Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment.
Darsova D; Pochop P; Uhlik J; Klapkova E; Tesfaye H; Kodetova D; Lestak J; Malis J; Vajner L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):318-23. PubMed ID: 22660213
[TBL] [Abstract][Full Text] [Related]
12. Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
Qaddoumi I; Billups CA; Tagen M; Stewart CF; Wu J; Helton K; McCarville MB; Merchant TE; Brennan R; Free TM; Given V; Haik BG; Rodriguez-Galindo C; Wilson MW
Cancer; 2012 Nov; 118(22):5663-70. PubMed ID: 22516936
[TBL] [Abstract][Full Text] [Related]
13. Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma.
Kiratli H; Kocabeyoğlu S; Bilgiç S
J AAPOS; 2007 Aug; 11(4):404-5. PubMed ID: 17306997
[TBL] [Abstract][Full Text] [Related]
14. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
15. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
16. Activity of topotecan in retinoblastoma.
Chantada GL; Fandiño AC; Casak SJ; Mato G; Manzitti J; Schvartzman E
Ophthalmic Genet; 2004 Mar; 25(1):37-43. PubMed ID: 15255113
[TBL] [Abstract][Full Text] [Related]
17. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reaction after intravitreal injection of topotecan.
Narang S; Sindhu M; Kochhar S; Pandey AK; Goyal P
Indian J Ophthalmol; 2020 Aug; 68(8):1648-1649. PubMed ID: 32709802
[No Abstract] [Full Text] [Related]
20. Fibrin sealant for retinoblastoma: where are we?
Martin NE; Kim JW; Abramson DH
J Ocul Pharmacol Ther; 2008 Oct; 24(5):433-8. PubMed ID: 18788992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
